Phase 3 Trial of Autologous Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma
Clinical trial NCT01582672 · TERMINATED
Trial details
- NCT number
- NCT01582672
- Sponsor
- Argos Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2018-04-01
- Enrollment
- 462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.